London School of Hygiene & Tropical Medicine
Sedona has nine years’ experience in economic evaluation in low- and middle-income countries. Her research focuses on the improving understanding of the economic impact of substantial long-term health shocks, both at the provider level and within the household. Her research to date has been focused on measurement and understanding of the costs of chronic illness – including HIV, TB, chronic non-communicable diseases, and HCV.
She is a member of the Task Force on Catastrophic Cost Measurement for TB, and is a co-investigator of the Value-TB project; a Bill and Melinda Gates funded multi-country costing study of TB interventions. She is also involved with the Global Health Costing Consortium, in which she focuses on costing standards and methods.
Sweeney S, Vassall A, Guinness L, Siapka M, Chimbindi N, Mudzengi D, Gomez GB. Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due To Tuberculosis from Small-Scale Studies in South Africa. PharmacoEconomics. 2020 Apr 1.
Research keywords: health economics, tuberculosis, catastrophic costs, economic evaluation, methods